Menu
Recruiting NCT07514546

Investigation of The Effect of Video-Assisted Laughter Yoga

No phase Interventional Laughter Yoga

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Session 1: Laughter Yoga, Session 2: Laughter Yoga, Session 3: Laughter Yoga, Session 4: Laughter Yoga.
Who it may be relevant to
Registry conditions: Laughter Yoga. Basic parameters: 18 years — 24 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of The Effect of Video-Assisted Laughter Yoga on Pain and Menstrual Symptoms in Primary Dysmenorrhea

Overview

This study is planned to examine the effect of video-assisted laughter yoga on pain and menstrual symptoms among students studying at a university in Türkiye. Data will be collected at the Faculty of Health Sciences, Konya Karatay University, between November 2025 and April 2026. The study population will consist of students aged 18 to 24 years studying at the Faculty of Health Sciences during the specified period. The sample size was calculated using the G Power computer program. Using a power analysis at the α=0.05 level, the effect size was calculated as 150, 153 (d=0.8), and the working power was calculated as 90%, indicating that at least 68 students should be included in the sample. Students meeting the research criteria and agreeing to participate in the study will be randomly assigned to an experimental group and a control group. The socio-demographic data of the students in the Faculty of Health Sciences, the Visual Analog Scale to assess students' pain, and the Menstrual Symptom Scale to measure menstrual symptoms, prepared by the researcher in accordance with the literature, will be used.

Detailed description

Research data will be collected face-to-face by the researcher. The study will be conducted with students who meet the inclusion criteria (being a student in the Faculty of Health Sciences, being willing to participate in the research, and being open to communication and collaboration). Pre-test assessment tools will be administered to the participating students. Following this, Laughter Yoga practice will be conducted. A total of 24 sessions will be implemented. Final post-test data will be administered after the last session.

Interventions

  • Behavioral Session 1: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 2: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 3: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 4: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 5: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 6: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 7: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 8: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 9: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.
  • Behavioral Session 10: Laughter Yoga
    Each session includes hand clapping and warm-up exercises, deep breathing techniques, childlike playfulness activities, structured laughter exercises, and a brief relaxation phase.

Primary outcome measures

  • Demographic Information Form [Time frame: up to 1 day]
Secondary outcome measures (1)
  • Visual Analog Scale (VAS) [Time frame: up to 1 day]

Eligibility criteria

Inclusion criteria

  • Students with regular menstrual periods (lasting 3-8 days, with a menstrual cycle range of 21-35 days)
  • Students with dysmenorrhea pain intensity of 45 mm or more according to the Visual Analog Scale (VAS).

Exclusion criteria

  • Students diagnosed with secondary dysmenorrhea (endometriosis, ovarian cyst/tumor, pelvic infectious disease, myoma, uterine polyps, uterine adhesions, infection, etc.),
  • those using oral contraceptives,
  • those with compromised tissue integrity in the abdominal area,
  • those with any chronic or mental illness.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • KTO Karatay Üniversitesi — Konya

Identifiers

NCT: NCT07514546 · SSAHIN0003

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗